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Background: No study has previously investigated whether the speed of recovery from disorientation in
the post-ictal period may predict the short-term treatment outcome of electroconvulsive therapy (ECT).
Methods: This longitudinal cohort study included 57 elderly patients with unipolar or bipolar major
depression, aged 60–85 years, treated with formula-based ECT. Treatment outcome was assessed weekly
during the ECT course using the 17-item Hamilton Rating Scale for Depression (HRSD17). The post-ictal
reorientation time (PRT) was assessed at the ﬁrst and third treatments.
Results: Longer PRTs at the ﬁrst and third treatments predicted a more rapid decline and a lower end-
point in continuous HRSD17 scores (p¼0.002 and 0.019, respectively). None of the patients who re-
covered from disorientation in less than 5 min met the remission criterion, deﬁned as an HRSD17 score of
7 or less. A greater increment in stimulus dosage from the ﬁrst to the third ECT session rendered a
smaller relative decline in PRT (po0.001).
Limitations: The limited number of subjects may reduce the generalizability of the ﬁndings.
Conclusions: The speed of recovery from disorientation at the ﬁrst and third sessions seems to be a
predictor of the treatment outcome of formula-based ECT, at least in elderly patients with major de-
pression. It remains to be clariﬁed how the PRT may be utilized to guide stimulus dosing.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Empirical data from controlled trials for optimizing the efﬁcacy
of electroconvulsive therapy (ECT) are insufﬁcient. Research in this
ﬁeld has primarily focused on technical parameters related to the
characteristics and delivery of the ﬁrst stimulus, as charge, pulse
width, pulse frequency, and electrode placement (Kellner et al.,
2010; Loo et al., 2015; Sackeim et al., 2000, 2008; Sienaert et al.,
2009). Less is known about how to evaluate the adequacy of the
ﬁrst treatment and how to adjust the dosage at subsequentB.V. This is an open access article u
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(T. Magne Bjølseth).sessions based on the patient’s acute response to the stimulus.
This tailoring approach has a strong clinical relevance to the ad-
ministration of ECT, also in geriatric psychiatry. The age-based
estimation of seizure threshold is customarily used in Norway
(Schweder et al., 2011). It is reported to result in lower remission
rates than titrated dosing because elderly patients with high sei-
zure thresholds tend to be under-treated (Tiller and Ingram, 2006).
Conversely, compared to the titration procedure, the age and half-
age methods (Abrams, 2002; Petrides et al., 2009) offer less
cumbersome and possibly safer ways to establish the stimulus
dose because frail elderly patients are not exposed to delayed re-
covery, unnecessary risk of cognitive deﬁcits or vagus-mediated
bradycardia from repeated sub-convulsive stimuli (Bennett et al.,
2012; Rasmussen, 2001). Moreover, adjusting the dosage along the
ECT course may compensate for the shortcomings of formula-
based ECT if ictal or post-ictal variables associated with stimulus
dosing and treatment outcome can be identiﬁed. Such parametersnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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remission, thus reducing the risk of exposing patients to cognitive
side effects to no avail.
Although the use of electroencephalogram (EEG) morphology
as a predictor of treatment outcome remains in dispute, certain
EEG characteristics such as post-ictal suppression and high am-
plitude spike-and-wave activity have shown robust predictive
capacities (Azuma et al., 2011; Kimball et al., 2009; Perera et al.,
2004; Mayur, 2006; Suppes et al., 1996). Hence, the American
Psychiatric Association (2001) stated that low amplitude mid-
seizure EEG expression or the absence of post-ictal suppression
can be taken as further evidence for the need to increase stimulus
dosage in patients who show inadequate responses to ECT.
Based on the assumption that ECT helps lift depression by sti-
mulating diencephalic structures, Swartz (2000) studied the effect
of peak heart rate (HR) on treatment outcome because peak ictal
HR largely reﬂects seizure activity in the brainstem (Swartz, 2009).
However, more recent studies did not corroborate the ﬁnding of a
relationship between peak HR, stimulus dosage and efﬁcacy
(Azuma et al., 2011; Nagler, 2013). Conﬂicting results give reasons
to question the role of peak HR as a marker for seizure adequacy.
Corresponding with the theory that generalized seizures af-
fecting the prefrontal cortex and the central subcortical structures
are essential for ECT to be effective (Michael, 2009), the time to
recover from disorientation may be a promising candidate for a
clinical variable that can be utilized to predict treatment outcome
and guide stimulus dosing. Consciousness and orientation usually
resume within an hour after a generalized tonic-clonic seizure.
Disorientation in the post-ictal period has been linked to a de-
crease in cerebral blood ﬂow in the fronto-parietal association
cortex (Blumenfeld, 2012; Yu and Blumenfeld, 2009). The post-
ictal reorientation time (PRT) was originally recorded to assess the
acute cognitive side effects of ECT (Prudic et al., 1994; Sackeim
et al., 1986). Sobin et al. (1995) and Martin et al. (in press) found
prolonged disorientation to be predictive of retrograde amnesia
for personal information following ECT. Conversely, this ﬁnding
was not corroborated in a recent trial (Sienaert et al., 2010) in
which the reorientation time was measured at three time points
and not continuously after the resumption of spontaneous re-
spiration. Although mean PRT tended to be longer with more ef-
ﬁcacious treatments in studies comparing electrode placements
and dosing regimens (McCall et al., 2000; Sackeim et al., 1993,
2000), no study has investigated this relationship.
Given that the time to recover from disorientation may reﬂect
seizure adequacy, we hypothesize that elderly depressed patients
with longer PRTs early in the ECT course are more likely to respond
to treatment compared to those who reach orientation sooner. To
test our hypothesis, we assessed whether longer PRTs at the ﬁrst
and third sessions were predictive of a more favorable time trend
for symptom severity when treated with formula-based ECT. Be-
cause it has less relevance for prediction, the PRT at subsequent
sessions was not analyzed. Additionally, we explored whether an
increment in stimulus dose from the ﬁrst to the third session was
associated with a longer PRT. If so, the PRT may be utilized to guide
stimulus dosing.2. Methods
2.1. Study design
This longitudinal cohort study originates from a single-site,
assessor-blinded, controlled, parallel-group trial with balanced 1:1
randomization comparing the efﬁcacy of formula-based bifrontal
(BF) vs. right unilateral (RUL) ECT. Subjects treated with BF or RUL
ECT were merged into one group consisting of 57 patients becausethe sample was relatively small. Moreover, there were no sig-
niﬁcant differences in efﬁcacy and PRT between the patients al-
located to BF or RUL electrode placement (Bjølseth et al., 2015).
The study is registered at the online clinical trial database Clin-
icaltrials.gov (NCT01559324). The randomized phase of the study
took place between September 1, 2009 and May 1, 2013, and the
treatment outcome of the randomized clinical trial (RCT) has re-
cently been published (Bjølseth et al., 2015).
2.2. Study population
Norwegian-speaking in-hospital patients aged 60–85 years
with major depressive episodes as deﬁned by the DSM-IV-TR cri-
teria (American Psychiatric Association, 2000), either unipolar or
bipolar, and referred for ECT, were eligible for inclusion. Additional
inclusion criteria were a minimum baseline score of 18 on the 17-
item Hamilton Rating Scale for Depression (HRSD17; Hamilton,
1960; Williams, 1988) and the ability to co-operate in testing and
to give voluntary informed consent.
Exclusion criteria included a Mini Mental State Examination
(MMSE, Engedal et al., 1988; Folstein et al., 1975) score of 23 (of
30) or less, a diagnosis of dementia, Parkinson’s disease, schizo-
phrenia or schizoaffective disorder, alcohol or substance abuse in
the three weeks prior to ECT, medical conditions contradicting ECT
and having received ECT in the six months preceding the study.
All patients were recruited from the Department of Geriatric
Psychiatry at the Diakonhjemmet Hospital, a public hospital ser-
ving approximately 230,000 inhabitants of the western and cen-
tral parts of Oslo, of which 28,000 were aged 65 years or older.
2.3. Treatment
2.3.1. Psychotropic medication
Forty-eight (84.2%) patients had not responded to at least one
adequate trial of an antidepressant prior to admission. For those in-
dividuals, antidepressants were reduced or withdrawn 3–10 days
before starting ECT. Thirty-four (59.6%) patients received anti-
depressants in sub-therapeutic doses during the ECT course, whereas
antidepressants were withdrawn in 14 (24.6%). Altogether, 44 (77.2%)
patients were in need of oxazepam for anxiety (5–15 mg/day up to
15 h prior to ECT). No one received diazepam. Zopiclon (3.75–7.5 mg)
was accepted in case of insomnia. The dosages of oxazepam and
zopiclon were converted to a deﬁned daily dosage and are listed in
Table 1. In 10 (17.5%) patients, anti-epileptic drugs or mood stabilizers
were discontinued one week prior to ECT. Olanzapin (2.5–20 mg/
day) or quetiapin (50–200 mg/day) were prescribed to 27 (47.4%)
patients with psychotic symptoms or agitation.
2.3.2. ECT
All treatments were administered after hyper-oxygenation for at
least 1 min with 100% oxygen under mask anesthesia with atropine
(0.5–1.0 mg), thiopental (2.5–3.5 mg/kg) and succinylcholine
(0.7 mg/kg), all of which were given intravenously. For ECT using
the BF position, each electrode was placed 5 cm above the outer
angle of the orbit on a line parallel to the sagittal plane (Letemendia
et al., 1993). The d’Elia placement was used for RUL ECT (d’Elia,
1970). Treatment was administered twice weekly using a Thyma-
tron system IV (Somatics, LLC, Lake Bluff, IL, USA), which delivered a
square-wave brief-pulse (0.5–1.0 ms pulse width) bidirectional
current at 0.9 A and 10–70 Hz, depending on the stimulus intensity.
The initial stimulus dose was determined using the age method
(Abrams, 2002) in cases of unilateral stimulation and the half-age
method (Petrides et al., 2009) in cases of bifrontal stimulation. The
dose was adjusted for sex. Women were administered ﬁve energy
percent (25 mC) less than the amount derived from the age or half-
age formula, and men were administered ﬁve energy percent more.
Table 1
Demographic and clinical characteristics of major depressed elderly patients treated with electroconvulsive therapy (ECT).
Characteristics Elderly patients with major depression (n¼57)
Demographic characteristics
Age, mean (SD), years 75.5 (6.3)
Female, n (%) 30 (52.6)
Clinical characteristics
Unipolar depression, n (%) 49 (86.0)
Bipolar depression, n (%) 8 (14.0)
Psychotic symptoms, n (%) 15 (26.3)
Melancholic symptoms, n (%) 54 (94.7)
Co-morbid anxiety disorder, n (%) 13 (22.8)
Previous alcohol abuse, n (%) 6 (10.5)
Failed trials ofZ2 ADs of different classes, n (%) 20 (35.1)
History of ECT, n (%) 17 (29.8)
First episode before the age of 60, n (%) 32 (56.1)
Time since onset of ﬁrst episode, median (range), months 216 (0–694)
Duration of index episode, median (range), weeks 24 (3–288)
MMSE, mean (SD) 27.4 (1.9)
Total CIRS-G score, mean (SD) 6.5 (3.6)
DDD of antidepressants at baseline, median (range) 0.5 (0–3.0)
DDD of benzodiazepines at baseline, median (range) 0.5 (0–1.5)
Treatment outcome of ECT
HRSD17 score at baseline, mean (SD) 23.3 (4.6)
HRSD17 score after ECT, mean (SD) 8.6 (5.9)
Decline in HRSD17 score, mean (SDa) 14.7 (7.0)
No. of ECT sessions among remittersb, mean (SD) 8.3 (2.7)
No. of ECT sessions among non-remitters, mean (SD) 10.5 (3.4)
Post-ictal reorientation time
PRT – ﬁrst assessment, ﬁrst ECT, median (range) (min) 12 (2–50)
PRT – second assessment, third ECT, median (range) (min) 11 (2–31)
PRT – last assessment, median (range) (min) 10 (2–50)
PRT during the ECT course, median (range) (min) 11 (4–50)
PRT during the ECT course, mean (SD) (min) 14.1 (10.0)
No. of PRT assessments during the ECT course, mean (SD) 6.5 (1.9)
Treatment details
BF electrode placement, n (%) 29 (50.9)
RUL electrode placement, n (%) 28 (49.1)
Thiopental dose – ﬁrst ECT, mean (SD) (mg/kg) 3.6 (0.6)
Thiopental dose – third ECT, mean (SD) (mg/kg) 3.6 (0.7)
Thiopental dose during the ECT course, mean (SD) (mg/kg) 3.8 (0.8)
Stimulus dose of the ﬁrst BF ECT, mean (SD) (mC) 194.7 (31.7)
Stimulus dose of the ﬁrst RUL ECT, mean (SD) (mC) 358.2 (51.8)
Stimulus dose of the third BF ECT, mean (SD) (mC) 239.8 (95.2)
Stimulus dose of the third RUL ECT, mean (SD) (mC) 375.3 (40.7)
Stimulus dose of the lastc BF ECT, mean (SD) (mC) 346.7 (239.6)
Stimulus dose of the lastc RUL ECT, mean (SD) (mC) 404.9 (111.9)
SD, standard deviation; AD, antidepressant; MMSE, Mini Mental State Examination; CIRS-G, Cumulative Illness Rating Scale; DDD, deﬁned
daily dosage; HRSD17, 17-item Hamilton Rating Scale for Depression; BF, bifrontal; RUL, right unilateral.
a SD not adjusted for intra-correlations due to repeated measurements.
b Remission deﬁned as an HRSD17 score of 7 or less.
c The ECT session when the last assessment of PRT was performed.
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cuffed arm and EEG manifestations of less than 15 s duration), re-
stimulation took place 20 s or 45 s later using either a 50% or 100%
increased dose (American Psychiatric Association, 2001). At sub-
sequent sessions, the stimulus dosage was adjusted according to the
duration, amplitude and coherence of electroencephalogram delta
waves (American Psychiatric Association, 2001), post-ictal sup-
pression (Azuma et al., 2007), peak post-ictal HR (Swartz, 2002),
and Clinical Global Impression Improvement score (Leon et al.,
1993) on the following day, as assessed by the patient and the ward
nurse.
Treatments were continued until the patient achieved remis-
sion or until a plateau in the patient’s beneﬁt was reached, up to a
maximum of 16 sessions.2.4. Assessment
2.4.1. Diagnostic procedures
Using all available information from in-ward observations, pa-
tient interviews, the next of kin and the referring GP, the diagnosis
of major depression (MD) according to the DSM-IV-TR criteria was
conﬁrmed by consensus between two independent and experi-
enced senior consultants in geriatric psychiatry. In addition, they
administered the Mini-International Neuropsychiatric Interview,
speciﬁcally the MINI-Plus (Mordal et al., 2010; Sheehan et al.,
1998), to support the diagnosis of MD and to screen for psychiatric
co-morbidity. Scoring on the Cumulative Illness Rating Scale for
Geriatric Patients was performed by the patient’s therapist, with
the exception of the psychiatric item (Miller et al., 1992), to
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2.4.2. Evaluation of treatment outcome
Two assessors, a study psychologist and a trained test assistant,
conducted the assessments of depressive symptoms. The HRSD17
was used to assess the decline in symptom severity. The ﬁrst as-
sessment of symptom severity was carried out at baseline, on an
average of four days before the ﬁrst ECT treatment. Thereafter,
patients were assessed every Wednesday between every second
session and on average four days after the last ECT treatment.
Inter-rater reliability on the HRSD17 between the study psycholo-
gist and the test assistant was tested and found to be high, with an
intra-class correlation of 0.90.
2.4.3. Deﬁnition of treatment outcome and drop-outs
The primary outcome was the longitudinal proﬁle of HRSD17
scores over the treatment course. Remission was deﬁned as an
HRSD17 score of 7 or less (Rush et al., 2006; Zimmerman et al.,
2013). Patients who terminated the treatment course prematurely
were considered to be drop-outs but were included in the
analyses.
2.4.4. Assessment and deﬁnition of post-ictal reorientation time
The PRT was assessed according to the protocol described by
Sackeim et al. (1986). It was recorded at the ﬁrst and third treat-
ments and thereafter at every second session if it was logistically
feasible. However, from the ﬁfth session and onward we had
missing values for some patients. Assessments of the PRTs were
timed relative to the assessments of depressive symptoms during
the ECT course. Hence, the PRT at the third treatment was recorded
two days after the second assessment of symptom severity (visit
1). On the morning prior to each treatment, it was determined
whether the patient met the criterion for full orientation, deﬁned
as being able to answer correctly four of ﬁve questions about
name, place, day of the week, age, and date of birth. On ﬁve oc-
casions, three patients did not know the place and which day it
was. On four occasions, another two patients did not know where
they were prior to ECT. After the resumption of spontaneous re-
spiration, a nurse started a stopwatch and asked the patient to
open his or her eyes. Following eye opening, the patients were
continuously requested to state their names. Once the names were
correctly reported, requests were made for the patients to identify
where they were, the day of the week, their age and birth date.
These questions were asked continuously. In case the answer was
wrong or missing, the nurse carried on with the remaining ques-
tions and then returned to the one to which the patient failed to
respond correctly. Practice effects were regarded as very small;
measures of orientation in subjects with brain dysfunction not
being prone to learning frommultiple testing (Wilson et al., 2000).
The PRT was deﬁned as the minutes that passed until the patient
was able to answer correctly four of the ﬁve above-mentioned
questions. In case the criterion for full orientation was not met in
the ﬁrst place, the number of minutes that passed until the patient
answered correctly the questions mastered beforehand was de-
ﬁned as the PRT. In the post-ictal period, patients unable to re-
spond correctly to all ﬁve questions did not know the place or
which day it was. The procedure was not conducted when ox-
azepam was given to manage post-ictal agitation and delirium
because oxazepam was likely to hamper the patient’s effort to re-
orientate, leading to one missed PRT value at the third ECT session.
Adjustment of the original protocol became necessary for elderly
patients; those not meeting the criterion for full orientation before
treatment were also included. For pragmatic reasons, a maximum
score (50 min) was given if disorientation persisted after 40 min.
This ceiling value was given to six patients on eleven occasions
during the ECT course. Because the recovery from seizure-inducedunresponsiveness and disorientation was of interest, the PRT was
timed relative to spontaneous respiration, and not relative to eye
opening.
2.5. Ethics
The study, including permission to use ECT in both moderate
and severe MD and as a ﬁrst-line treatment in selected cases, was
approved by the Regional Committee for Research Ethics in Nor-
way. In the week following admission, eligible patients and their
next of kin were given thorough written and oral information
about ECT, the purpose of the trial and the procedures involved.
Inclusion was based strictly on informed consent with the pa-
tient’s signature.
2.6. Statistical analyses
All analyses were conducted using SPSS version 22.0 and SAS
version 9.3. The results with p values of 0.025 or less were con-
sidered statistically signiﬁcant. All tests were two-sided.
2.6.1. Descriptive analyses
Demographic and clinical characteristics were presented as
means and standard deviations (SDs) for continuous symme-
trically distributed data, whereas skewed data were presented as
medians and ranges. Categorical variables were presented as fre-
quencies and percentages. To achieve normal distributions, mea-
sures of PRT were subjected to logarithmic transformation prior to
descriptive analysis. To explore whether PRT at the ﬁrst ECT ses-
sion was associated with demographic, clinical or treatment
characteristics, scores were compared across electrode placement
groups, between males and females, between those who were and
were not in need of benzodiazepines at baseline, and between
those who were and were not administered larger than the aver-
age dose of thiopental. Comparisons of scores were also performed
between patients who did and did not present with psychotic
symptoms, mild cognitive impairment, previous alcohol abuse,
early-onset depression, bipolar disorder, melancholic symptoms,
anxiety disorder or resistance to pharmacotherapy. These com-
parisons were performed using an independent samples t test.
2.6.2. Missing data
The HRSD17 scores for six patients that lacked baseline data
were imputed using inclusion values. This was assumed to be valid
because symptom severity was not likely to change signiﬁcantly
during the ﬁve days (on average) that passed between inclusion
and baseline assessment. For ﬁve patients, missing PRT data at the
third ECT session were imputed from those recorded at the fourth
treatment because reorientation time did not change signiﬁcantly
from the third session and onward.
2.6.3. Outcome analyses
Time-trend in PRT during the treatment course was assessed
using a linear mixed model with ﬁxed effects for ﬁrst- and second-
order time component and with random effects for intercepts.
Electrode placement was entered into the model as ﬁxed effect
together with its interaction with time. A linear regression model
was used to assess the relationship between the PRT (at the ﬁrst,
second and last assessment) and the stimulus dosage at the cor-
responding session. Associations between the difference in PRT
between the ﬁrst and second, and the ﬁrst and last assessment, as
well as the relative difference in PRT from the ﬁrst to the second
assessment, and the corresponding increment in stimulus dosage
were also estimated by linear regression models. Adjustments for
electrode placement and remitter status were performed using
multivariate linear regression models. The results were presented
Fig. 1. Trajectories of observed and estimated mean scores for the 17-item Hamilton Rating Scale for Depression (HRSD17) during the electroconvulsive therapy (ECT) course.
The number of patients assessed at each time point were: baseline (57) and visits 1 (57), 2 (57), 3 (55), 4 (43), 5 (31), 6 (23), 7 (14), and 8 (7).
Fig. 2. (A) Trajectories of observed mean post-ictal reorientation times (PRTs) within right unilateral (RUL) and bifrontal (BF) electrode placement groups at ﬁrst and third
sessions of electroconvulsive therapy (ECT) and last time assessed. The number of patients assessed at each time point: (RUL/BF) 28/29. (B) Trajectories of estimated mean
PRTs within RUL and BF electrode placement groups at ﬁrst and third sessions of ECT and last time assessed.
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(SEs) and p-values.
Time-trend in treatment outcome was assessed using a linear
mixed model with ﬁxed effects for ﬁrst-, second-, and third-order
time components and with random effects for intercepts. The
main predictors, the PRTs at the ﬁrst and third ECT sessions, were
assessed in the models as ﬁxed effects together with their inter-
action with time. Whereas symptom severity at baseline was in-
cluded when estimating the effects of PRT at the ﬁrst session on
the trajectory of HRSD17 scores, it was excluded when estimating
the effects of PRT at the third session on the time trend. Finally, the
models were adjusted for the following seven a priori chosen
covariates: age, dosage of thiopental (mg/kg), daily deﬁned dosage
of benzodiazepines, electrode placement, global cognitive func-
tion, the presence of psychosis and symptom severity at baseline
using the Montgomery and Aasberg Depression Rating Scale
(MADRS; Montgomery and Aasberg, 1979). The adjustment vari-
ables were chosen on clinical grounds and have previously been
shown to correlate with either ECT treatment outcome or PRT
(Bjølseth et al., 2015). The interactions between time and psy-
chosis and between psychosis and PRT were assessed. The models
were reduced by applying Akaike’s Information Criterion, where a
smaller value represents a better model. Interactions were left in
the models only if signiﬁcant. The results were presented as re-
gression coefﬁcients with the corresponding SEs and p-values.
Because the models contained interactions, the results were also
presented graphically for easier interpretation.3. Results
3.1. Participant ﬂow
In the original RCT, a total of 79 patients were randomized, but
six had no post-baseline assessments (Bjølseth et al., 2015). An
additional 16 patients were excluded from this study because we
failed to record their PRTs at the ﬁrst treatment session for various
reasons. This yielded a total sample of 57 patients.
3.2. Characteristics
Table 1 lists demographic and clinical characteristics of the
study population. Fifteen (26.3%) patients had psychotic symp-
toms, and 20 (35.1%) were resistant to pharmacotherapy in that
they failed at least two trials of different-class antidepressants.
Twenty-nine (50.9%) patients displayed mild cognitive impairment
at baseline, deﬁned as an MMSE score of 27 points or less (Strobel
and Engedal, 2008).
When comparing the PRT at the ﬁrst ECT session across de-
mographic, clinical and treatment categories, no signiﬁcant group
differences were found except in the category of thiopental ad-
ministered below or above the average dosage. Patients who
needed 3.6 mg/kg or more had signiﬁcantly shorter reorientation
times (p¼0.009). We did not perform post-hoc analyses assessing
whether the dose of the barbiturate had a confounding effect on
the relationship between PRT and the treatment outcome because
there was no signiﬁcant difference in the mean thiopental dose
Table 2
Explorative analyses of the associations between post-ictal reorientation time (PRT)
and stimulus dosage, and between PRT and treatment outcome of the electro-
convulsive therapy (ECT) coursea in elderly patients with major depression (n¼57).
Variable Association with corresponding stimulus dose
Crude association Adjusted association
R.c.(SE)b pc R.c. (SE) pd
PRT – ﬁrst ECT 0.02
(0.02)
0.156 0.001 (0.04) 0.852
PRT – third ECT 0.007
(0.007)
0.348 0.004 (0.01) 0.721
PRT – last
assessmente
0.002
(0.007)
0.786 0.002 (0.007) 0.722
Association with corresponding increment in stimulus
dose
Crude association Adjusted association
R.c. (SE) pc R.c. (SE) pd
Diff. PRT – ﬁrst to
third ECT
0.05 (0.02) 0.005 0.05
(0.02)
0.015
Relative diff. PRT
– ﬁrst to third
ECT
0.45 (0.09) o 0.001 0.44
(0.10)
o 0.001
Diff. PRT – ﬁrst
ECT to last
assessment
0.02 (0.01) 0.021 0.02
(0.01)
0.034
Effect on longitudinal corresponding proﬁle of
HRSD17 mean scores
Crude effect Adjusted effect
R.c. (SE) pf R.c. (SE) pg
PRT – ﬁrst ECT 0.10 (0.05) 0.043 0.08 (0.12) 0.491
PRT – ﬁrst
ECT time
0.007 (0.002) 0.002 0.007 (0.002) 0.002
PRT – third ECT 0.07 (0.13) 0.577 0.09 (0.12) 0.425
PRT – third
ECT time
0.01 (0.004) 0.013 0.009 (0.004) 0.019
Mean PRT during
the ECT course
0.02 (0.07) 0.739 0.02 (0.05) 0.644
Mean PRT time 0.002 (0.001) 0.165
a Models for 17-item Hamilton Rating Scale for Depression (HRSD17) scores
from baseline contain time components up to third-order.
b R.c., regression coefﬁcient.
c p value from a bivariate linear model.
d p value from a multivariate linear model (adjusted for electrode placement
and remitter status).
e The ECT session when the last assessment of PRT was performed.
f p value from a bivariate linear mixed model.
g p value from a multivariate linear mixed model (adjusted for PRT, age, thio-
pental dose, daily deﬁned dosage of benzodiazepines, electrode placement, the
Mini Mental State Examination (MMSE) and Montgomery and Aasberg Depression
Rating Scale (MADRS) scores at baseline and psychosis).
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(p¼0.469).
3.3. ECT treatment outcome
The mean (SD) change in HRSD17 scores from baseline to the
end of the ECT treatment was 14.7 (7.0) points (Table 1). The tra-
jectories of the observed and estimated HRSD17 mean scores are
shown in Fig. 1. According to the linear mixed model, there was a
signiﬁcant non-linear downward tendency in HRSD17 during the
ECT course (po0.001).3.4. PRT and stimulus dosage
There was a signiﬁcant decline in estimated mean PRT from the
ﬁrst to the third treatment (p¼0.001) and from the ﬁrst to the last
time PRT was assessed (p¼0.025). Although not signiﬁcantly, the
PRT tended to increase between the third treatment and last as-
sessment (p¼0.185). There were no signiﬁcant differences re-
garding how PRT changed across electrode placement groups
(p¼0.857) (Fig. 2). Whereas no associations were found between
the stimulus dosage per se and the PRT, a multivariate linear re-
gression model showed that the difference in reorientation time
from the ﬁrst to the second and from the ﬁrst to the last assess-
ments was signiﬁcantly associated with the corresponding incre-
ments in stimulus dose (p¼0.015 and 0.034, respectively) (see
Table 2). A signiﬁcant association was also found between the
relative difference in PRT from the ﬁrst to the second assessment
and the corresponding increment in stimulus dose (po0.001)
Thus, a greater increment in dosage rendered a smaller absolute
and relative decline in PRT.
3.5. PRT and treatment outcome
We assessed the association between the PRT and the long-
itudinal proﬁle of HRSD17 scores over the ECT course using a linear
mixed model. Adjusting for covariates minimally altered the re-
sults for the time-trend. In Table 2, crude and adjusted regression
coefﬁcients quantifying the effects of each PRT measure on the
trajectory of HRSD17 scores are listed. According to the ﬁnal model,
a longer reorientation time at the ﬁrst and third ECT treatments
predicted a more rapid decline and a lower end-point in HRSD17
scores. We found signiﬁcant interactions between time and the
PRT at the ﬁrst and third ECT sessions before adjustment for the
covariates. These interactions remained signiﬁcant in the ﬁnal
multivariate model.
In Fig. 3, the diverging trajectories of estimated HRSD17 mean
scores for patients with reorientation times of 5 and 35 min at the
ﬁrst and third sessions are shown. They illustrate that patients
with longer PRTs met the remission criterion after fewer treat-
ments. In the models, none of the patients who recovered from
disorientation in less than ﬁve minutes met the remission criter-
ion, whereas patients with PRTs of 35 min or more achieved re-
mission after 12 treatments or less. In Fig. 4, the similar trajec-
tories of the HRSD17 scores for patients with and without psy-
chotic symptoms are presented. The interaction between psy-
chosis and the reorientation time at the ﬁrst session could not be
eliminated from the model according to Akaike’s Information
Criterion (p¼0.064). Fig. 4 shows that the difference in which
delusional patients with various reorientation times improved
from depression was greatest during the ﬁrst treatments, whereas
non-delusional patients with comparable reorientation times ex-
perienced a diverging decline in symptom severity at the end of
the ECT course.
There was no signiﬁcant association between the mean PRT and
the treatment outcome (Table 2).4. Discussion
To the best of our knowledge, this is the ﬁrst study in-
vestigating whether the PRT may be predictive of the short-term
treatment outcome of ECT. Although mean PRT tended to be
longer with more efﬁcacious methods in some trials (McCall et al.,
2000; Sackeim et al., 1993, 2000), other studies did not corrobo-
rate this tendency (Loo et al., 2008; Sackeim et al., 2008). Con-
ﬂicting results may have dampened the interest for studying the
predictive value of the PRT in relationship to treatment outcome.
Fig. 3. (A) Trajectories of estimated mean scores for the 17-item Hamilton Rating Scale for Depression (HRSD17) during the electroconvulsive therapy (ECT) course for
patients with post-ictal reorientation times (PRTs) of 5 and 35 min at the ﬁrst session. * Indicates visits at which the differences were statistically signiﬁcant. The cut-off for
deﬁning remission on the HRSD17 is indicated by a dotted line. (B) Trajectories of estimated mean scores for HRSD17 during the ECT course for patients with PRTs of 5 and
35 min at the third session.
Fig. 4. Trajectories of estimated mean scores for the 17-item Hamilton Rating Scale for Depression (HRSD17) during the electroconvulsive therapy (ECT) course for non-
delusional and delusional patients with post-ictal reorientation times (PRTs) of 5 and 35 min at the ﬁrst ECT session.
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signiﬁcant association between the average PRT across the ECT
course and the treatment outcome. This ﬁnding may explain why
mean reorientation time did not provide additional information
when comparing the efﬁcacy of different ECT treatment mod-
alities. The reason, apart from regression to the mean, may be that
the PRT initially declined, which was likely a result of the antic-
onvulsant action of ECT (Michael, 2009; Sackeim et al., 1987),
before tending to increase later on in the treatment course. Thus,
the average value obscured the variation in the reorientation time
between patients in the beginning of the treatment course,
whereas the PRTs at the ﬁrst and third sessions seem to reﬂect
seizure adequacy. Additionally, the relationship between an ultra-
short PRT and treatment outcome was complex, an early awa-
kening being associated with a poor outcome after an initial im-
provement of symptom severity. An explanation may be the
temporary relief felt by patients not suffering from the acute
cognitive effects of ECT.
Moreover, our explorative analyses shed light on the variables
that determined the extent of post-ictal disorientation. Contrary to
our expectations, we did not ﬁnd a signiﬁcant association between
absolute stimulus dose and reorientation time. Sackeim et al.
(1986) suggested that the extent to which the stimulus dosageexceeds seizure threshold may be a stronger determinant of the
PRT than dosage per se. The fact that we found a shorter reor-
ientation time among patients who were in need of the average
dose of thiopental or more lent support to this view because the
barbiturate increases seizure threshold and decreases seizure
duration (Kellner et al., 2009).
Given that the PRT is determined by the stimulus dose relative
to seizure threshold, the decline in reorientation time from the
ﬁrst to the third treatment implied that the anticonvulsant prop-
erty of ECT most probably outweighed the increment in dosage.
However, the PRT did not change signiﬁcantly from the third ECT
session to the last time it was assessed. In sine wave bitemporal
ECT, a prolongation of reorientation time was observed as treat-
ment progressed (Daniel and Crovitz, 1982, 1983; Fraser and Glass,
1978). Although such cumulative detrimental effects on cognition
have not been demonstrated in RUL ECT (Martin et al., in press;
Sackeim et al., 1986), it may be that the PRT tended to increase
from the third session and onward because the acute cognitive
side effects did not subside between the last sessions. If so, the PRT
mainly reﬂects seizure adequacy early in the treatment course.
Apart from predicting the treatment outcome, the PRT must be
shown to correlate with stimulus dosing before it can be utilized
to optimize efﬁcacy during the ECT course. It is promising that a
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session rendered a smaller absolute and relative decline in PRT
indicating that a higher stimulus dose may improve outcome in
case the PRT is ultra-short.
Our ﬁndings showed that patients who recovered from dis-
orientation in less than ﬁve minutes at the ﬁrst and third sessions
were unlikely to achieve remission. This result corresponds with
the clinical observation by D’Elia et al. (1983) of seizures followed
by early awakening lacking efﬁcacy. Such rapid reorientation
should prompt attempts to improve seizure adequacy by increas-
ing the dose considerably at the next session, for example by 50%.
If the reorientation time remains ultra-short, the patient is at high
risk of being exposed to cognitive side effects to no avail. More-
over, our analyses indicate that PRTs of 35 min or more initially
may predict a highly favorable treatment outcome because the
time trend for HRSD17 scores in those instances traversed the cut-
off for remission after 12 or less ECT sessions. More research is
warranted to determine whether the stimulus dose should be
maintained in those instances and whether a moderate increment
in dose may improve the speed of response when the PRT ranges
between 5 and 35 min.5. Limitations
The limited number of subjects may reduce the generalizability
of our ﬁndings. However, the PRT was recorded from the ﬁrst ECT
session and onward in 57 of the 73 participants (78%) in our ori-
ginal sample. This yielded a relatively large and representative
study population for non-demented elderly patients with MD re-
ceiving formula-based ECT as part of a regular clinical practice.
A ceiling value of 50 min was given to patients unable to re-
cover from disorientation after 40 min. The real intra- and inter-
individual variation in PRT was reduced by not assessing the re-
orientation time in confused and frail elderly patients any further.
Additionally, deﬁning reorientation as correct responses to four of
ﬁve questions about name, place and time (Sackeim et al., 1986)
resulted in a considerably shorter PRT compared to the time
needed to correctly answer all questions. The patients strived to
know where they were or the day of the week after treatment, and
it has been shown that reorientation time is short for name, longer
for place and longest for time (Calev et al., 1991). These approaches
may have led to an under-estimation of the predictive value of
PRT. This challenge may be overcome by measuring the actual
time it takes patients to respond correctly to all ﬁve questions up
to a maximum of 90 min.
The rationale for stopping antidepressants before ECT was to
reduce the risk of additive cognitive side-effects and cardio-vas-
cular instability (Kranaster et al., 2012; Song et al., 2015). Hence,
tapering off antidepressants may have reduced PRT, implying that
our ﬁndings may not be generalizable to clinical settings in which
antidepressants are continued during an ECT course.
Use of the HRSD17 as a primary outcome measure may have led
to an under- or over-estimation of the efﬁcacy of ECT in delusional
patients. The sum of its item scores has recently been found to
have limited validity for assessing the severity and improvement
of psychotic depression (Ostergaard et al., 2014a) because only
those delusions and hallucinations with very speciﬁc themes can
be rated. In future research, these shortcomings can be overcome
by using a new composite rating scale, the Psychotic Depression
Assessment Scale, which has demonstrated good content and
clinical validity (Ostergaard et al., 2014b).
We cannot exclude the possibility that multiple comparisons
may have resulted in spurious ﬁndings (type I error).6. Conclusion
In the context of a relatively small sample of elderly non-de-
mented patients with MD, the PRT at the ﬁrst and third sessions
seemed predictive of the short-term treatment outcome of ECT.
Our results indicate that a longer PRT reﬂects a more efﬁcacious
seizure and that the speed of recovery from disorientation may
supplement EEG characteristics in tailoring stimulus dosing for
elderly patients, at least early in the treatment course of formula-
based ECT. It remains to be established whether our ﬁndings are
generalizable beyond the elderly population and beyond formula-
based methods. Further research is also warranted to clarify how
the PRT may be utilized to guide stimulus dosing.Role of funding source
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